医学
间歇气动压缩
淋巴水肿
绷带
乳腺癌
压迫绷带
压迫疗法
生活质量(医疗保健)
外科
物理疗法
癌症
内科学
护理部
血栓形成
静脉血栓栓塞
作者
Sibel Özkan Gürdal,Alis Kostanoğlu,İkbal Çavdar,Ayfer Özbaş,Neslihan Cabıoğlu,Beyza Özçınar,Abdullah İğci,Mahmut Müslümanoğlu,Vahit Özmen
标识
DOI:10.1089/lrb.2012.0002
摘要
Background: The aim of this prospective controlled study was to assess the efficacy of two different combination treatment modalities of lymphedema (LE). Manual lymphatic drainage (MLD) and compression bandage combination (complex decongestive therapy) have been compared with intermittent pneumatic compression (IPC) plus self-lymphatic drainage (SLD). Methods and Results: Both MLD with compression bandage (complex decongestive therapy) group (Group I, n=15) and IPC with SLD group (Group II, n=15) received treatment for LE 3 days in a week and every other day for 6 weeks. Arm circumferences were measured before and the 1st, 3rd, and 6th weeks of the treatment. EORTC-QLQ and ASES-tests were performed to assess the quality of life before and after 6 week-treatment. Patients in both groups had similar demographic and clinical characteristics. Even though both treatment modalities resulted in significant decrease in the total arm volume (12.2% decrease in Group II and 14.9% decrease in Group I) (p<0.001), no significant difference (p=0.582) was found between those two groups. Similarly, ASES scores were significantly (p=0.001) improved in both Group I and II without any significant difference between the groups. While emotional functioning, fatigue, and pain scores were significantly improved in both groups, global health status, functional and cognitive functioning scores appeared to be improved only in patients of group I. Conclusions: Different treatment modalities consisting of MLD and compression bandage(complex decongestive therapy) or IPC and SLD appear to be effective in the treatment of LE with similar therapeutic efficacy in patients with breast cancer. However, combination modalities including IPC and SLD may be the preferred choices for their applicability at home.
科研通智能强力驱动
Strongly Powered by AbleSci AI